?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
187 Unternehmen gefunden • Seite 4 von 8
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() | Protagonist Therapeutics Inc | 37.5 | Arzneimittel (Biotechnologie) | USA | 9.6 Mrd. USD | 115.65 | 74.17 | 34.00 | 11.39 | ▲ 9.96% | ▲ 14.49% | - | - | - | -282.83% | ▲ 87.98% | -343.63% | ▲ 78.52% | 121.87% | ▲ 149.23% | 5 / 9 | 13,32 | unbegrenzt | 7 / 100 | −28,0 / 100 | −6,83 |
![]() | Evolus Inc | 37.5 | Arzneimittel (Pharmazeutisch) | USA | 0.5 Mrd. USD | - | - | 1.64 | -16.76 | ▲ 39.36% | ▼ -20.54% | - | - | - | -17.38% | ▲ 9.03% | -12.65% | ▲ 9.48% | -17.07% | ▲ 8.66% | 3 / 9 | −8,61 | −2,1-fach | 85 / 100 | −4,2 / 100 | −2,60 |
![]() | Ardelyx Inc | 37.5 | Arzneimittel (Biotechnologie) | USA | 0.9 Mrd. USD | - | - | 2.05 | 6.20 | ▲ 121.90% | ▼ -8.17% | - | - | - | -15.12% | ▲ 321.98% | -10.06% | ▲ 315.10% | -10.80% | ▲ 315.78% | 3 / 9 | −2,22 | −1,9-fach | 73 / 100 | −3,8 / 100 | −2,34 |
![]() | Foghorn Therapeutics Inc | 37.5 | Arzneimittel (Biotechnologie) | USA | 0.3 Mrd. USD | - | - | 7.14 | -3.24 | ▲ 135.14% | ▲ 1.55% | - | - | - | -240.33% | ▲ 1506.55% | -265.64% | ▲ 1489.79% | -278.72% | ▲ 611.54% | 3 / 9 | −9,87 | - | 14 / 100 | 6,0 / 100 | - |
| CAMP4 THERAPEUTICS CORPORATION | 37.5 | Arzneimittel (Biotechnologie) | USA | 0.3 Mrd. USD | - | - | 63.26 | -384.85 | ▼ -59.18% | ▲ 7.38% | - | - | - | -2298.54% | ▼ -1251.06% | -1488.31% | ▼ -1110.15% | -852.83% | ▼ -873.51% | 4 / 9 | −6,47 | −37,9-fach | 2 / 100 | −43,2 / 100 | −1,02 | |
| Avalo Therapeutics Inc | 37.5 | Arzneimittel (Biotechnologie) | USA | 0.9 Mrd. USD | - | - | 14652.80 | 10.41 | ▼ -61.19% | ▲ 4.27% | - | - | - | -132642.37% | ▼ -26989.35% | -123601.69% | ▼ -25948.85% | -87216.95% | ▼ -18277.82% | 3 / 9 | −9,25 | −17,6-fach | 0 / 100 | −23,0 / 100 | −6,78 | |
![]() | Geron Corporation | 37.5 | Arzneimittel (Biotechnologie) | USA | 0.9 Mrd. USD | - | - | 4.24 | 3.97 | ▲ 273.49% | ▲ 2.55% | - | - | - | -46.65% | ▲ 4015.96% | -29.28% | ▲ 3932.99% | -60.41% | ▲ 3478.82% | 3 / 9 | −5,84 | −6,5-fach | 31 / 100 | 4,4 / 100 | −1,81 |
![]() | Arrowhead Pharmaceuticals Inc | 35.9 | Arzneimittel (Biotechnologie) | USA | 11.7 Mrd. USD | - | - | 17.48 | 25.14 | ▲ 56.63% | ▼ -54.60% | - | - | - | -0.20% | ▼ -1660.67% | 11.86% | ▼ -1661.44% | 18.91% | ▼ -1711.65% | 6 / 9 | 1,00 | −4,5-fach | 62 / 100 | −13,4 / 100 | - |
![]() | CareDx Inc | 35.6 | Arzneimittel (Biotechnologie) | USA | 2.6 Mrd. USD | 23.42 | 30.57 | 5.68 | 6.11 | ▲ 14.59% | ▲ 2.67% | - | - | - | -5.62% | ▲ 4.90% | -6.60% | ▲ 4.31% | 9.51% | ▲ 7.06% | 6 / 9 | −0,60 | - | 62 / 100 | −15,3 / 100 | −3,30 |
![]() | Arcturus Therapeutics Holdings Inc | 34.9 | Arzneimittel (Biotechnologie) | USA | 0.4 Mrd. USD | - | - | 17.59 | 2.44 | ▲ 47.77% | ▼ -1.83% | - | - | - | -97.86% | ▲ 303.72% | -111.51% | ▲ 298.46% | -110.83% | ▲ 196.34% | 2 / 9 | 1,07 | −224,0-fach | 24 / 100 | 3,1 / 100 | −0,98 |
![]() | Natera Inc | 34.8 | Arzneimittel (Biotechnologie) | USA | 47.4 Mrd. USD | - | 661.30 | 17.51 | 26.03 | ▲ 42.61% | ▼ -1.95% | - | - | - | -9.03% | ▲ 18.83% | -13.44% | ▲ 17.57% | 4.73% | ▲ 19.23% | 6 / 9 | 0,71 | −31,6-fach | 60 / 100 | −16,9 / 100 | 0,41 |
![]() | Zymeworks Inc. Common Stock | 34.4 | Arzneimittel (Biotechnologie) | USA | 1.9 Mrd. USD | - | - | 50.54 | 23.35 | ▲ 22.16% | ▼ -14.79% | - | - | - | -76.56% | ▲ 124.40% | -87.33% | ▲ 123.05% | -32.58% | ▲ 129.71% | 6 / 9 | −3,28 | - | 31 / 100 | −13,9 / 100 | −3,55 |
![]() | Emergent Biosolutions Inc | 34.2 | Arzneimittel (Biotechnologie) | USA | 0.3 Mrd. USD | - | 3.72 | 0.41 | 0.94 | ▼ -13.98% | ▼ -29.68% | - | - | - | 7.08% | ▼ -1.12% | 14.83% | ▼ -0.40% | 21.11% | ▲ 4.82% | 6 / 9 | 3,66 | −2,6-fach | 27 / 100 | −9,0 / 100 | −3,48 |
![]() | Tarsus Pharmaceuticals Inc | 34.0 | Arzneimittel (Pharmazeutisch) | USA | 3.7 Mrd. USD | - | 60.30 | 6.12 | 10.70 | ▲ 68.30% | ▲ 19.89% | - | - | - | -14.72% | ▲ 19.64% | -15.72% | ▲ 18.82% | -4.94% | ▲ 12.47% | 5 / 9 | 3,03 | −15,1-fach | 75 / 100 | −9,6 / 100 | −1,66 |
![]() | Janux Therapeutics Inc | 33.8 | Arzneimittel (Biotechnologie) | USA | 1.1 Mrd. USD | - | - | 32.79 | 1.13 | ▲ 92.33% | ▲ 75.71% | - | - | - | -1136.25% | ▼ -50.49% | -1576.67% | ▼ -149.71% | -832.78% | ▼ -49.45% | 3 / 9 | 24,11 | - | 1 / 100 | −3,1 / 100 | −1,94 |
![]() | MacroGenics Inc | 33.3 | Arzneimittel (Biotechnologie) | USA | 0.3 Mrd. USD | - | - | 1.52 | 5.94 | ▲ 8.87% | ▼ -8.72% | - | - | - | -49.91% | ▲ 43.85% | -48.72% | ▲ 44.41% | -55.49% | ▲ 29.67% | 3 / 9 | −12,73 | −12,6-fach | 41 / 100 | 2,5 / 100 | −0,19 |
![]() | Amneal Pharmaceuticals, Inc. Class A Common Stock | 32.7 | Arzneimittel (Pharmazeutisch) | USA | 5.9 Mrd. USD | 37.65 | 71.29 | 1.90 | 179.40 | ▲ 8.66% | ▼ -4.57% | - | - | - | 2.39% | ▲ 0.55% | 14.02% | ▲ 2.67% | 8.94% | ▲ 0.84% | 8 / 9 | 2,14 | 1-fach | 32 / 100 | −7,4 / 100 | −2,59 |
![]() | AnaptysBio Inc | 32.5 | Arzneimittel (Biotechnologie) | USA | 1.6 Mrd. USD | - | 361.76 | 6.86 | 125.13 | ▲ 25.62% | ▼ -7.87% | - | - | - | -5.64% | ▲ 126.39% | 20.42% | ▲ 121.42% | 8.36% | ▲ 73.66% | 6 / 9 | 0,05 | −1,2-fach | 64 / 100 | −9,0 / 100 | −3,44 |
![]() | Viridian Therapeutics Inc | 32.4 | Arzneimittel (Biotechnologie) | USA | 2.4 Mrd. USD | - | - | 33.83 | 3.63 | ▲ 132.18% | ▲ 25.35% | - | - | - | -483.57% | ▼ -7766.47% | -512.91% | ▼ -8708.32% | -390.81% | ▼ -6883.01% | 4 / 9 | 2,91 | −85,4-fach | 8 / 100 | −7,4 / 100 | - |
![]() | Castle Biosciences Inc | 31.1 | Arzneimittel (Biotechnologie) | USA | 1.0 Mrd. USD | - | - | 2.76 | 2.10 | ▲ 40.60% | ▲ 18.63% | - | - | - | -7.02% | ▲ 10.70% | -12.44% | ▲ 11.61% | 8.23% | ▲ 10.97% | 4 / 9 | 6,30 | −95,9-fach | 47 / 100 | −15,3 / 100 | −3,50 |
![]() | Tango Therapeutics Inc | 31.1 | Arzneimittel (Biotechnologie) | USA | 4.0 Mrd. USD | - | - | 60.29 | 25.05 | ▲ 52.13% | ▲ 14.35% | - | - | - | -162.85% | ▲ 11.41% | -178.39% | ▲ 5.81% | -224.31% | ▲ 3.80% | 4 / 9 | 5,74 | - | 15 / 100 | 9,4 / 100 | - |
![]() | Nurix Therapeutics Inc | 30.1 | Arzneimittel (Biotechnologie) | USA | 2.6 Mrd. USD | - | - | 70.85 | 6.47 | ▲ 36.35% | ▲ 43.64% | - | - | - | -314.90% | ▲ 23.31% | -340.16% | ▲ 19.77% | -313.73% | ▲ 8.98% | 5 / 9 | 1,42 | - | 9 / 100 | −2,2 / 100 | −5,12 |
![]() | Legend Biotech Corp | 30.1 | Arzneimittel (Biotechnologie) | USA | 3.6 Mrd. USD | - | - | 2.85 | 2.95 | ▲ 68.83% | ▲ 2.19% | - | - | - | -28.85% | ▲ 141.78% | -13.27% | ▲ 145.45% | -16.33% | ▲ 84.18% | 3 / 9 | −0,95 | −13,8-fach | 36 / 100 | −11,3 / 100 | −2,70 |
![]() | Relay Therapeutics Inc | 29.4 | Arzneimittel (Biotechnologie) | USA | 4.1 Mrd. USD | - | - | 399.54 | 4.65 | ▼ -28.58% | ▲ 39.46% | - | - | - | -1800.58% | ▲ 3808.61% | -1971.59% | ▲ 3808.61% | -1536.08% | ▲ 1683.43% | 6 / 9 | 3,25 | - | 2 / 100 | −6,6 / 100 | - |
![]() | Cytokinetics Inc | 29.2 | Arzneimittel (Biotechnologie) | USA | 10.3 Mrd. USD | - | - | 144.53 | -59.12 | ▲ 9.54% | ▲ 43.88% | - | - | - | -891.60% | ▼ -395.17% | -695.44% | ▼ -342.18% | -607.48% | ▼ -250.69% | 5 / 9 | −8,23 | −6,7-fach | 5 / 100 | −19,3 / 100 | −3,30 |